|
English
|
正體中文
|
简体中文
|
Total items :2853537
|
|
Visitors :
45257378
Online Users :
932
Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 653306-653315 of 2346288 (234629 Page(s) Totally) << < 65326 65327 65328 65329 65330 65331 65332 65333 65334 65335 > >> View [10|25|50] records per page
| 國立臺灣大學 |
2015 |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang, Yih-Leong; Yang, Ching-Yao; Lin, Mong-Wei; Wu, Chen-Tu; Yang, Pan-Chyr; 吳振都; 張逸良; 楊泮池; 楊景堯; 林孟暐 |
| 臺大學術典藏 |
2020-02-20T02:56:58Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; CHING-YAO YANG; Lin M.-W.; Wu C.-T.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:23Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Lin M.-W.; Wu C.-T.; Yang P.-C.; Yang C.-Y.; YIH-LEONG CHANG; Yih-Leong Chang;Yang C.-Y.;Lin M.-W.;Wu C.-T.;Yang P.-C. |
| 臺大學術典藏 |
2015 |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Lin M.-W.; Wu C.-T.; Yang P.-C.; CHING-YAO YANG; Chang Y.-L. |
| 臺大學術典藏 |
2020-12-02T02:33:30Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; Pan-Chyr Yang; Chang Y.-L.; Yang C.-Y.; Lin M.-W.; Wu C.-T.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-10-08T08:16:31Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; MONG-WEI LIN; Wu C.-T.; Yang P.-C. |
| 臺大學術典藏 |
2022-03-04T05:33:34Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang Y.-L.; Yang C.-Y.; Lin M.-W.; CHEN-TU WU; Yang P.-C. |
| 臺大學術典藏 |
2018-09-10T15:27:10Z |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy.
|
Chang, Yih-Leong;Yang, Ching-Yao;Lin, Mong-Wei;Wu, Chen-Tu;Yang, Pan-Chyr; Yih-Leong Chang, Ching-Yao Yang, Mong-Wei Lin, Chen-Tu Wu, Pan-Chyr Yang; 吳振都;張逸良;楊泮池;楊景堯;林孟暐; Chang, Yih-Leong; CHING-YAO YANG; CHEN-TU WU; Yang, Ching-Yao; Lin, Mong-Wei; YIH-LEONG CHANG; Wu, Chen-Tu; Yang, Pan-Chyr |
| 臺大學術典藏 |
2022-09-06T01:55:22Z |
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients
|
Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen |
| 國家衛生研究院 |
2020-11-03 |
PD-L1/PD-1 blockade in breast cancer: The immunotherapy era (Review)
|
Li, CJ;Lin, LT;Hou, MF;Chu, PY |
Showing items 653306-653315 of 2346288 (234629 Page(s) Totally) << < 65326 65327 65328 65329 65330 65331 65332 65333 65334 65335 > >> View [10|25|50] records per page
|